Cargando…
Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Progression
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor therapeutic responses and short survival. The identification of factors that make PDAC so deadly and their targeting is important. Sulforaphane has shown promise in experimental and epidemiological studies,...
Autores principales: | Luo, Yiqiao, Yan, Bin, Liu, Li, Yin, Libo, Ji, Huihui, An, Xuefeng, Gladkich, Jury, Qi, Zhimin, De La Torre, Carolina, Herr, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920255/ https://www.ncbi.nlm.nih.gov/pubmed/33669381 http://dx.doi.org/10.3390/cancers13040827 |
Ejemplares similares
-
Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer
por: Yin, Libo, et al.
Publicado: (2019) -
Sulforaphane Targets TRA-1/GLI Upstream of DAF-16/FOXO to Promote C. elegans Longevity and Healthspan
por: Ji, Huihui, et al.
Publicado: (2021) -
UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis
por: Luo, Yiqiao, et al.
Publicado: (2022) -
Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer
por: An, Xuefeng, et al.
Publicado: (2021) -
Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells
por: LABSCH, SABRINA, et al.
Publicado: (2014)